Lonza is a preferred global partner in the pharmaceutical, biotech, and nutrition markets. We focus on enabling treatments that prevent illness and support healthier lifestyles. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers. We provide a wide range of services and products from early-phase discovery to custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. Our scale and resources mean we can provide a one-stop solution for our customers to help people get well, feel well, and stay well. In 2022, we supported more than 825 preclinical and clinical small and large molecules, more than 195 commercial small and large molecules, and produced around 250 billion capsules.